5.1(top 3%)
Impact Factor
5.4(top 3%)
extended IF
140(top 2%)
H-Index
5.3K
authors
5.9K
papers
174.8K
citations
6.3K
citing journals
77K
citing authors

Most Cited Articles of European Journal of Pharmaceutical Sciences

TitleYearCitations
Modeling and comparison of dissolution profiles20013.4K
Nanosizing: a formulation approach for poorly-water-soluble compounds2003975
Novel mechanisms and devices to enable successful transdermal drug delivery2001838
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system2006835
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs2000833
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems2000787
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer2009678
Transport of drugs from the nasal cavity to the central nervous system2000657
Drug targeting2000589
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics2013546
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles2005503
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability2004482
Gene delivery by lipoplexes and polyplexes2010471
Pharmacological properties of the ubiquitous natural product betulin2006470
Liposomes and skin: from drug delivery to model membranes2008442
Transporters as a determinant of drug clearance and tissue distribution2006425
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs2000409
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation2001403
Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide1999403
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells2000397
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers2002395
Dendrimers: emerging polymers for drug-delivery systems2009392
Microencapsulated chitosan nanoparticles for lung protein delivery2005371
The applications of Vitamin E TPGS in drug delivery2013368
When poor solubility becomes an issue: from early stage to proof of concept2007367